🔧На сайте запланированы технические работы
25.12.2025 в промежутке с 18:00 до 21:00 по Московскому времени (GMT+3) на сайте будут проводиться плановые технические работы. Возможны перебои с доступом к сайту. Приносим извинения за временные неудобства. Благодарим за понимание!
🔧Site maintenance is scheduled.
Scheduled maintenance will be performed on the site from 6:00 PM to 9:00 PM Moscow time (GMT+3) on December 25, 2025. Site access may be interrupted. We apologize for the inconvenience. Thank you for your understanding!

 

Modes of Hypotensive Action of Dihydroquercetin in Arterial Hypertension


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription Access

Abstract

We studied the effect of dihydroquercetin (20 mg/kg/day intragastrically for 6 weeks) on mean BP and macro- and microrheological blood parameters in hypertensive SHR rats; in vitro effect of dihydroquercetin on the tone in thoracic aorta rings isolated from hypertensive SHR rats were also examined. At the end of the treatment course, the mean BP in the experimental rats decreased by 11%; the left ventricular mass index by 2%, and whole blood viscosity by 7-10% in comparison with control SHR rats; erythrocyte aggregation half-time increased by 15%; plasma viscosity, hematocrit, and erythrocyte deformability did not change. In in vitro experiments, dihydroquercetin (10—8-10—6M) induced relaxation of the isolated thoracic aorta rings in a dose-dependent manner. Hence, the antihypertensive effect of dihydroquercetin results from the decrease in blood viscosity and vasodilation.

About the authors

M. B. Plotnikov

Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Author for correspondence.
Email: mbp2001@mail.ru
Russian Federation, Tomsk

O. I. Aliev

Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: mbp2001@mail.ru
Russian Federation, Tomsk

A. V. Sidekhmenova

Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: mbp2001@mail.ru
Russian Federation, Tomsk

A. Yu. Shamanaev

Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: mbp2001@mail.ru
Russian Federation, Tomsk

A. M. Anishchenko

Laboratory of Circulation Pharmacology, E. D. Goldberg Research Institute of Pharmacology and Regenerative Medicine

Email: mbp2001@mail.ru
Russian Federation, Tomsk

A. V. Nosarev

Department of Biophysics and Functional Diagnostics, Siberian State Medical University

Email: mbp2001@mail.ru
Russian Federation, Tomsk

E. A. Pushkina

Department of Biophysics and Functional Diagnostics, Siberian State Medical University

Email: mbp2001@mail.ru
Russian Federation, Tomsk

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2017 Springer Science+Business Media New York